Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FAPI-74 PET in Gastrointestinal Cancers
NCT05641896Phase 2Completed
- Sponsor
- SOFIE
- Start
- Apr 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]-FAPI-74 in gastrointestinal cancer, sponsored by SOFIE. Started Apr 2023; status: completed.
02
Drugs
[18F]-FAPI-74
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on NCT05641896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05641896.